NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox) - PubMed (original) (raw)

NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox)

R Riek et al. Eur J Biochem. 2001 Nov.

Free article

Abstract

NMR studies of amyloid beta-peptides (A beta) in aqueous solution provide a novel way in which to characterize the apparent Alzheimer's disease-related conformational polymorphism of A beta. In the aqueous medium, neither of the polypeptides A beta(1-40)(ox) or A beta(1-42)(ox) (both of which contain a methionine sulfoxide at position 35) is folded into a globular structure, but they both deviate from random coil behavior by local conformational preferences of several short segments along the amino-acid sequence. Differences between the solution structures of A beta(1-40)(ox) and A beta(1-42)(ox) are indicated only by decreased flexibility of the region from about residue 32 to the C-terminus in A beta(1-42)(ox) when compared to A beta(1-40)(ox). The lack of the observation of more extensive conformational differences between the two molecules is intriguing, considering that A beta(1-42)(ox) in aqueous solution has much higher plaque-competence than A beta(1-40)(ox).

PubMed Disclaimer

Cited by

Varied Probability of Staying Collapsed/Extended at the Conformational Equilibrium of Monomeric Aβ40 and Aβ42.
Song W, Wang Y, Colletier JP, Yang H, Xu Y. Song W, et al. Sci Rep. 2015 Jun 5;5:11024. doi: 10.1038/srep11024. Sci Rep. 2015. PMID: 26046578 Free PMC article.
Amide solvent protection analysis demonstrates that amyloid-beta(1-40) and amyloid-beta(1-42) form different fibrillar structures under identical conditions.
Olofsson A, Lindhagen-Persson M, Sauer-Eriksson AE, Ohman A. Olofsson A, et al. Biochem J. 2007 May 15;404(1):63-70. doi: 10.1042/BJ20061561. Biochem J. 2007. PMID: 17280549 Free PMC article.
Stabilization of discordant helices in amyloid fibril-forming proteins.
Päiviö A, Nordling E, Kallberg Y, Thyberg J, Johansson J. Päiviö A, et al. Protein Sci. 2004 May;13(5):1251-9. doi: 10.1110/ps.03442404. Protein Sci. 2004. PMID: 15096631 Free PMC article.
Effects of familial Alzheimer's disease mutations on the folding nucleation of the amyloid beta-protein.
Krone MG, Baumketner A, Bernstein SL, Wyttenbach T, Lazo ND, Teplow DB, Bowers MT, Shea JE. Krone MG, et al. J Mol Biol. 2008 Aug 1;381(1):221-8. doi: 10.1016/j.jmb.2008.05.069. Epub 2008 Jun 4. J Mol Biol. 2008. PMID: 18597778 Free PMC article.
Alpha-helix targeting reduces amyloid-beta peptide toxicity.
Nerelius C, Sandegren A, Sargsyan H, Raunak R, Leijonmarck H, Chatterjee U, Fisahn A, Imarisio S, Lomas DA, Crowther DC, Strömberg R, Johansson J. Nerelius C, et al. Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9191-6. doi: 10.1073/pnas.0810364106. Epub 2009 May 20. Proc Natl Acad Sci U S A. 2009. PMID: 19458258 Free PMC article.

NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox) - PubMed (original) (raw)